4-BroMo-1-fluoro-2-(propylaMinoMethyl)benzene
|
- $211 - $564
- Product name: 4-BroMo-1-fluoro-2-(propylaMinoMethyl)benzene
- CAS: 1016496-17-5
- MF: C10H13BrFN
- MW: 246.12
- EINECS:
- MDL Number:MFCD09927562
- Synonyms:4-BroMo-1-fluoro-2-(propylaMinoMethyl)benzene;N-[(5-bromo-2-fluorophenyl)methyl]propan-1-amine;Benzenemethanamine, 5-bromo-2-fluoro-N-propyl-;n-(5-Bromo-2-fluorobenzyl)propan-1-amine
4 prices
Selected condition：
Brand
- AK Scientific
- Crysdot
- SynChem
Package
- 1g
- 5g
- 10g
- ManufacturerAK Scientific
- Product numberZ6368
- Product description4-Bromo-1-fluoro-2-(propylaminomethyl)benzene
- Packaging1g
- Price$211
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12187307
- Product description4-Bromo-1-fluoro-2-(propylaminomethyl)benzene 95+%
- Packaging5g
- Price$337
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12187307
- Product description4-Bromo-1-fluoro-2-(propylaminomethyl)benzene 95+%
- Packaging10g
- Price$564
- Updated2021-12-16
- Buy
- ManufacturerSynChem
- Product numberSC-40111c
- Product description4-Bromo-1-fluoro-2-(propylaminomethyl)benzene 95%
- Packaging1g
- Price$260
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | Z6368 | 4-Bromo-1-fluoro-2-(propylaminomethyl)benzene | 1g | $211 | 2021-12-16 | Buy |
| Crysdot | CD12187307 | 4-Bromo-1-fluoro-2-(propylaminomethyl)benzene 95+% | 5g | $337 | 2021-12-16 | Buy |
| Crysdot | CD12187307 | 4-Bromo-1-fluoro-2-(propylaminomethyl)benzene 95+% | 10g | $564 | 2021-12-16 | Buy |
| SynChem | SC-40111c | 4-Bromo-1-fluoro-2-(propylaminomethyl)benzene 95% | 1g | $260 | 2021-12-16 | Buy |
Properties
Boiling point :268.7±25.0 °C(Predicted)
Density :1.334±0.06 g/cm3(Predicted)
pka :8.65±0.19(Predicted)
Density :1.334±0.06 g/cm3(Predicted)
pka :8.65±0.19(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|